Surprisingly GH3 is a simple nutrient, the precise cell renovation is not always anticipated for any one user. Gerovital H3 operates at the cellular-level so its action is across the body rather than distinct. Changes originating from Gerovital-Procaine, are mostly inconspicuous.
People accustomed to the strong and immediate effects of prescription drugs seldom notice any changes in the short-term period of time. In evaluating the benefits, historical experience, demonstrate that it is desirable to assess its benefits over a period of a few months. Changes in both physical and psychological conditions can then can be evaluated. |
1. CAN GH3 IMPROVE SEXUAL PERFORMANCE?
Some investigators feel that impotence is caused by low neurotransmitter serotonin levels. Serotonin refers to a MAO substrate. Notably, MAO that emerges after 45 years thus accompanies decreasing serotonin levels. GH3 possesses a demonstrated capacity of inhibiting excess MAO. Therefore, it appears to normalise levels of serotonin and maintain potency. Additionally, the generation of androgen and estrogen could be an aspect in sexual performance and characteristics. Parhon, Aslan and Danila and Untea researched this area and concluded that GH3 having procaine hydrochloride appears to escalate the levels of deficient androgen and estrogen. Seemingly, this simulative impact is commonly exhibited where such factors are not normal. 2. HERPES AND GEROVITAL H-3?
Currently, a cure for herpes is yet to be formulated. However, J. Earle, a Southern California University official conducted a suitable research study. He demonstrated that herpes I and II viruses are deactivated when GH3 is present. 3. CANCER PREVENTION AND RISK WITH GH3?
A definite answer for this question does not exist. J Earle studies revealed that C-type (cancer causing) viruses are deactivated in GH3 experiments. Dr. Aslan cited a statistical decline in neoplasm appearance amongst patient populations through long-term Procaine hydrochloride GH3 injections. 4. GEROVITAL AND HEART ATTACK / STROKE?
There is scanty evidence regarding gerovital use. However, studies undertaken by Cohen and Ditman, as well as by Aslan showed a reduction in levels of cholesterol amongst patients who are on GH3 treatment. Moreover, the product’s tendency of normalising heart rate and arterial pressure may prove critical in averting circulatory system damage. During the 1974, National Professors Conference held in Italy , the scientists in attendance praised the efficiency of GH3 against cholesterol and blood clot accumulation. Furthermore, they consented that it lacks negative health implications. Taking GH3 has been found to trigger an immediate increase in levels of cholesterol. Notably, the increased levels are determined within the blood. A temporal increase could be an indication of arterial deposits mobilisation.
5. PROCAINE GH3 – ALLERGIC REACTIONS?
The immune system of the body reacts defensively to the existence of different substances obtained from the surroundings. However, it might be introduced to an antigen causing an overreaction. The ordinary protective response could backfire. The chemical effect for the natural function that has boomeranged may become a complex problem. There is an increase in histamine output capable of generating numerous classical allergic reaction symptoms. Moreover, stress may expose the body to allergic reactions when there is repetitive response from the adrenal glands. These may culminate in exhaustion of essential chemical defences. GH3 can mitigate these issues in different ways: (1) Ghali, Cohen and Aslan consider GH3 an anti-histamic (44) (2). Bucci has shown that it controls the adrenal reaction (3). Adrenaline is a partner of acetylcholine. Because DEAE is a forerunner of acetylcholine, it can enhance a parasympathetic response in stressful times.
6. CAN GEROVITAL HELP WITH HAIR RE-COLORATION AND GROWTH?
There is extensive scientific evidence, which shows that GH3 assist in hair re-grow and re-colour. Additionally, the pharmacological activity is yet to be understood properly. Notably, endocrine imbalances decrease circulation causing hair thinning and weakening. Poor or inadequate nutrition communication to the scalp can decrease the quality of hair. As mentioned earlier, GH3 assists in endocrine balance restoration. Gerovital enhances circulation to different body parts via vasodilatation. In addition, PABA has been found to be efficient in boosting the quality of hair. The GH3’s stabilised and ionised form can permit the PABA to function efficiently. The hair re coloring and re growing may not be experienced in all people. In the event that it occurs, it may take many years before significant outcomes are observed. In some cases, hair loss or poor quality of hair cannot be attributed to inadequate endocrines or nutrients. In such scenarios, GH3 is unnecessary.
|
 Bookmark |
|
7. CAN GH3 STRENGTHEN THE BODY AGAINST ORDINARY ILLNESS?
Dr. Aslan and her colleagues observed that 38% of participants on GH3 treatment indicated a decrease in work place absenteeism. Another two-year research by Untea and Bercu showed that 76% of employed workers increased their wages if on procaine HCl with Gerovital GH3. The same employees experienced higher levels of concentration and lack of fatigue in their activities. As mentioned earlier, a severe influenza outbreak occurred in Europe in one Romanian study. Dr. Aslan cited a mortality rate of 3.2 % amongst patients on GH3. With regard to the untreated group, the mortality rate was found to be 13.9%. A US report revealed similar outcomes with 3.3% representing GH3 users and 12.0% for the untreated users.
8. WHAT IS THE EFFECT OF MAO IN DEPRESSIVE CONDITIONS? COULD GEROVITAL HELP?
Apparently, the noreprinephrine and serotonin are required for accurate neural responses. Many investigators feel that inadequate levels cause depressive symptoms, which soon culminates in poor functioning, withdrawal and pessimistic fatigue. It has been found that MAO metabolises such neurotransmitters to prevent them from gaining prominence. If they become popular, they may cause manic behaviour and excessive neural firing. Conversely, when MAO increases to extreme levels, a neurotransmitters deficit is observed as the MAO functions accurately.GH3’s reported ability of balancing MAO actions can mitigate the anomaly. On the other hand, several MAO inhibitors (where a tyramine-restricted diet is required) GH3 functions as MAO’s reversible inhibitor. It separates the neurotransmitters from MAO, thus preventing excessive metabolisation. In duress or in tyramine presence, procaine is capable of reversing the action to enable MAO perform other relevant functions.
9. OSTEOPOROSIS AND GH3 THERAPY
Osteoporosis is mainly caused by bone structure breakdown and inadequate calcified tissue. It develops with age, thus identified amongst geriatric patients. However, NASA doctors discovered that space passengers under weightless state indicated an extreme osteoporosis development. Patients on GH3 treatment have exhibited a considerable decline in osteoporosis. Outcomes have been cited in its reversal and prevention. Seemingly Gerovital GH3 encourages calcium retention in the body. Furthermore, investigators suggest that remineralization for the entire skeleton can take place in several years. Moreover, a general bone thickening has been observed amongst GH3 treated patients. GH3 may control osteoporosis by stimulating androgens and estrogens as indicated earlier. The two hormones are currently utilised for treating the condition.
10. CAN GEROVITAL-H3 (GH3) HELP WITH SICKLE-CELL ANAEMIA?
Investigators in a laboratory study indicated that, when it encounters procaine, re-oxygenation of sickled cells would occur. They asserted that procaine in GH3 is in competition with calcium to acquire sites for membrane binding. It is believed that calcium causes haemoglobin brittleness. This was solely a laboratory study. However, the researchers asserted that procaine was ideal in overcoming sickle cell deformation.
11. DOES GEROVITAL GH3 AFFECT BLOOD SUGAR LEVELS?
There is scant information regarding the subject. One study indicated that the use of GH3 as the insulin adjunct could control the level of blood sugar in diabetic patients. Additionally, it is indicated that the level of blood sugar appeared to normalise in scenarios where there was slight aberration of values.
12. WILL GH3 IMPROVE STRESS LEVELS?
GH3 shows anti-adrenergic characteristics and acts as a relaxant of muscles. Both factors can provide significant stress resistance. As mentioned earlier, DEAE takes part in acetylcholine generation, the adrenaline counterpart. GH3 enhances toxin removal and excessive MAO inhibition. Moreover, investigators perceive these as stress reduction factors.
13. MULTIPLE SCLEROSIS – IS GH3 HELPFUL?
A German surgeon, Dr. Gohbrandt, undertook a clinical test on 87 patients with multiple sclerosis. The participants that were treated with tablets, ampoules and Gerovital injections exhibited significant improvement. An extensive clinical research is yet to be conducted in this field.
14. WHAT GH3 DO FOR WEIGHT MANAGEMENT?
Notably, GH3 may serve as a factor of creating uniformity. Apparently, patients in the degeneration condition may not maintain the required body mass. For instance, some geriatric patients, become emaciated after lean tissue loss. Studies show that GH3 anabolic properties can enhance weight increase. Similarly, a slow rate of metabolism can undermine catabolization of unnecessary body fat. Clinical investigation indicates that Gerovital H3 escalates the deficient rate of basal metabolism.
15. CAN GEROVITAL IMPROVE THE SKIN?
Medical investigations show that GH3 can facilitate the removal of wrinkles and age spots. Additionally, GH3 may enhance faster healing skin elasticity.Such changes may be attributed to increased circulation on the surface of the skin. Most GH3 users have been found acquire a youthful look; this disguises their chronological ages. Such observations are unnecessarily exaggerated. It can be assumed that early signs of ageing are characterised by the skin and hair appearance. Notably, these surface age measures tend to derive a positive effect from GH3. Scientific data holistically indicates that GH3 (Gerovital) may to a certain extent improve and prolong the quality of the skin.
|
Bookmark |
|
16. GH3 - DOES IT EXTEND LIFE?
France ’s Professor Berger and California ’s Richard Hochschild undertook the most important studies on life span increments. The two conducted independent researches. Their findings revealed that the life span of male animals was higher at 30% compared to that for controls. Notably, life span extensions in female animals were less significant. Moreover, Dr. Aslan’s longitudinal investigations indicated a drop in human mortality rate. It is worth recalling that the life span potential in human form is limited. Reproduction solely occurs through overproduction of body cells. The survival of the human system has been designed to last about 12 decades.
Afterwards, the reproductive potential of cells wanes rapidly. The extent to which an individual lives beyond this can be attributed to inadequate health management, accidents and stress. Dr. Aslan did not assert that GH3 increases the possibility of extending life beyond the limit; instead, she felt that there was a possibility for individuals to pass on early; however, at a higher age. The objective is to attain an advanced age without causing degenerative problems that usually emanate from the life quality.
17. OVERDOSE ON GH3?
Dr. Bernard Wagner from Columbia University undertook studies on GH3. Participants were administered over 60 times of normal GH3equivalent dose for a period of over 16 weeks. He discovered that procaine build up was non-existent within the cells. In view of this, Dr. Wagner noted that procaine functions in a similar manner as other B-vitamins that dissolve in water. Dr Wagner alongside other researchers concur that the function of GH3 within the body sites takes place in a unique manner. There is no tissue damage or alteration of the organism’s basic structure.
18. HOW DOES GH3 CURE HEALTH ISSUES?
The term “cure” is wrong because the concept being examined is a nutrient. Dr. Aslan suggests that the GH3’S actual significance lies in its ability to be utilised nutritionally in the reinforcement of specified health program’s medical treatment. Furthermore, Gerovital may offer a protection measure against health issues that are capable of developing.
19. IS GH3 ADDICTIVE?
Some users have reported strong addiction to benefits of GH3. However, they may not depend on it physically. Pharmacological studies undertaken by Goodman and Gilman indicate that procaine HCl in GH3 cannot cause addiction.
20. WHY ARE SULFONAMIDES AND NIACIN NOT RECOMMENDED WITH GH3?
Procaine effects may be neutralised using straight niacin and sulpha drugs. However, their interaction with GH3 is not harmful. PAB A antagonises sulphonamides, thus would result in a mutual reduction in efficiency. Niacin increases the size of blood vessels leading to rapid ejection of procaine from the system.
21. CAN GH3 IMPROVE DETOXIFICATION?
The mild toxins from water and food accumulating within the body can be attributed to GH3. This detoxification bears semblance to that witnessed on unprecedented change of vitamin program, fasting or nutritional intake. This healing problem encompasses influenza, mild nausea and headache. A low number of users on GH3 at 20% experience such conditions.
22. WHY IS A PAUSE PERIOD RECOMMENDED EVERY 25 DAYS?
A short period for resting without GH3 intake is recommendable. Consuming vitamins on a daily basis may result in reduced body response. Halting Gerovital use for some days monthly provides the cells with enough time of regaining sensitivity.
23. WHY HAS THE DISCOVERY OF GH3 BEEN DISCREDITED?
As explained earlier, GH3 is yet to be examined deeply. An allopathically based medical establishment would logically block a cheap vitamin that attempts to enhance an extensive variety of physical issues. However, the facts fail to explain such assumption. Indeed, several doctors are supportive of GH3 and availed it to patients. They feel that the positive attributes of GH3 outweigh the negative ones.
In general, numerous GH3 studies are not published in major US journals. On the other hand, reports indicating low efficiency have been accorded significant media coverage. Notably, 85% of the GH3 research concurs with Dr. Aslan’s initial allegations. About 100% of the research applying the correct formulation led to conclusions similar to those drawn by Dr. Aslan’s GH3.
The condition of medicine as an art, as in other fields, expands via information flow amongst trade journals. When some development fails to emerge, then the field practitioners discard it. Within the medical profession, failure to test the art’s condition can lead to legal cases and withdrawal of practitioner’s licence. Similarly, a registered practitioner who fails to present the art’s condition cannot be blamed.
Additionally, stressful factor is the focus directed towards patentable items. Pharmaceutical officials urge doctors to stay updated. Such primary information sources are inclined towards patent drugs that attract huge profits. Costly studies are not ideal investment when a product, for instance, GH3 cannot be patented. Lack of approval for human use renders GH3 an unnecessary drug within the medical perspective. It merely remains as a simple nutrient.
 Suggested further reading |
- GH3 - WILL IT KEEP YOU YOUNGER LONGER?
(Herbert Bailey, Bantam Books, Paperback). 1980
This is the "bible" on GH3 history and research. It is particularly valuable as it gives chapter and verse on the irrefutable evidence of the anti-aging benefits of GH3.
-
H3 IN THE BATTLE AGAINST OLD AGE (GH3) (Anti-aging)
(Henry Marx, Plenum Press, New York, hardback or paperback)
An excellent historical/medical account of GH3, with details of benefits in specific diseases groups and illustrations.
-
GEROVITAL GH3 (PROCAINE) THERAPY
(Bruce w. Halstead M.D., Golden Quills Publishers Inc., Colton CA)
-
GH3-CONFESSIONS OF A MEDICAL HERETIC
(Robert Mandelsohn, Warner Books, paperback)
-
GEROVITAL H3
By Professor Ana Aslan, 1982.
Published by Phoenix, Vancouver/Bucharest.
-
GH3
By Olga Franklin, 1964. Published by Arthur Baker Ltd. London (UK)
-
NOTES ON ASLAN GH3
1990-97. Research papers relating to the most advanced form of GH3 tablets available and
manufactured in a UK's government licenced laboratory.
|
